- Home
- WIW vs DNA Comparison
WIW vs DNA Comparison
Compare WIW & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIW
- DNA
- Stock Information
- Founded
- WIW 2004
- DNA 2008
- Country
- WIW United States
- DNA United States
- Employees
- WIW N/A
- DNA N/A
- Industry
- WIW Finance Companies
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WIW Finance
- DNA Health Care
- Exchange
- WIW Nasdaq
- DNA Nasdaq
- Market Cap
- WIW 523.7M
- DNA 423.5M
- IPO Year
- WIW N/A
- DNA N/A
- Fundamental
- Price
- WIW $8.55
- DNA $6.37
- Analyst Decision
- WIW
- DNA Hold
- Analyst Count
- WIW 0
- DNA 6
- Target Price
- WIW N/A
- DNA $37.80
- AVG Volume (30 Days)
- WIW 229.9K
- DNA 1.2M
- Earning Date
- WIW 01-01-0001
- DNA 11-12-2024
- Dividend Yield
- WIW 11.14%
- DNA N/A
- EPS Growth
- WIW N/A
- DNA N/A
- EPS
- WIW N/A
- DNA N/A
- Revenue
- WIW N/A
- DNA $217,951,000.00
- Revenue This Year
- WIW N/A
- DNA N/A
- Revenue Next Year
- WIW N/A
- DNA $12.85
- P/E Ratio
- WIW N/A
- DNA N/A
- Revenue Growth
- WIW N/A
- DNA N/A
- 52 Week Low
- WIW $8.01
- DNA $5.26
- 52 Week High
- WIW $9.37
- DNA $75.20
- Technical
- Relative Strength Index (RSI)
- WIW 31.48
- DNA 33.79
- Support Level
- WIW $8.65
- DNA $8.13
- Resistance Level
- WIW $8.82
- DNA $10.07
- Average True Range (ATR)
- WIW 0.08
- DNA 0.70
- MACD
- WIW -0.02
- DNA -0.14
- Stochastic Oscillator
- WIW 11.00
- DNA 8.87
About WIW Western Asset Inflation-Linked Opportunities & Income Fund
Western Asset Inflation-Linked Opportunities and Income Fund is a diversified, closed-end management investment company. Its primary investment objective of the group is to provide current income for its shareholders. The secondary investment objective is capital appreciation with current income.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.